BMI Badger Meter Forecast, Technical & Fundamental Analysis

BMI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2026

BMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 37 cases where BMI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 76%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on BMI as a result. In 65 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 185 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 28 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 58%.

BMI moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

The Aroon Indicator for BMI entered a downward trend on September 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.371) is normal, around the industry mean (4.255). P/E Ratio (29.632) is within average values for comparable stocks, (88.653). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.013) settles around the average of (0.004) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).

The Tickeron PE Growth Rating for this company is 69 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.